Women with Neurofibromatosis Type I (NF1)–a tumor predisposition syndrome caused by a germline NF1 mutation–have an increased risk of developing aggressive breast cancer with poorer prognosis. This evidence concerns the gene NF1 and BAP1-related tumor predisposition syndrome.